Cite
HARVARD Citation
Moore, D. et al. (2018). Cost savings analysis and toxicity audit of a bevacizumab dose rounding policy at a community cancer center. Journal of oncology pharmacy practice. pp. 42-46. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moore, D. et al. (2018). Cost savings analysis and toxicity audit of a bevacizumab dose rounding policy at a community cancer center. Journal of oncology pharmacy practice. pp. 42-46. [Online].